Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? - PubMed (original) (raw)
Review
Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?
Giovanni Musso et al. Diabetes Care. 2010 Oct.
Abstract
The connection between gut microbiota and energy homeostasis and inflammation and its role in the pathogenesis of obesity-related disorders are increasingly recognized. Animals models of obesity connect an altered microbiota composition to the development of obesity, insulin resistance, and diabetes in the host through several mechanisms: increased energy harvest from the diet, altered fatty acid metabolism and composition in adipose tissue and liver, modulation of gut peptide YY and glucagon-like peptide (GLP)-1 secretion, activation of the lipopolysaccharide toll-like receptor-4 axis, and modulation of intestinal barrier integrity by GLP-2. Instrumental for gut microbiota manipulation is the understanding of mechanisms regulating gut microbiota composition. Several factors shape the gut microflora during infancy: mode of delivery, type of infant feeding, hospitalization, and prematurity. Furthermore, the key importance of antibiotic use and dietary nutrient composition are increasingly recognized. The role of the Western diet in promoting an obesogenic gut microbiota is being confirmation in subjects. Following encouraging results in animals, several short-term randomized controlled trials showed the benefit of prebiotics and probiotics on insulin sensitivity, inflammatory markers, postprandial incretins, and glucose tolerance. Future research is needed to unravel the hormonal, immunomodulatory, and metabolic mechanisms underlying microbe-microbe and microbiota-host interactions and the specific genes that determine the health benefit derived from probiotics. While awaiting further randomized trials assessing long-term safety and benefits on clinical end points, a healthy lifestyle--including breast lactation, appropriate antibiotic use, and the avoidance of excessive dietary fat intake--may ensure a friendly gut microbiota and positively affect prevention and treatment of metabolic disorders.
Similar articles
- Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders.
Musso G, Gambino R, Cassader M. Musso G, et al. Curr Opin Lipidol. 2010 Feb;21(1):76-83. doi: 10.1097/MOL.0b013e3283347ebb. Curr Opin Lipidol. 2010. PMID: 19915460 Review. - Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD. Geurts L, et al. Benef Microbes. 2014 Mar;5(1):3-17. doi: 10.3920/BM2012.0065. Benef Microbes. 2014. PMID: 23886976 Review. - The gut microbiota, obesity and insulin resistance.
Shen J, Obin MS, Zhao L. Shen J, et al. Mol Aspects Med. 2013 Feb;34(1):39-58. doi: 10.1016/j.mam.2012.11.001. Epub 2012 Nov 16. Mol Aspects Med. 2013. PMID: 23159341 Review. - [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T, Suba I. Halmos T, et al. Orv Hetil. 2016 Jan 3;157(1):13-22. doi: 10.1556/650.2015.30296. Orv Hetil. 2016. PMID: 26708682 Review. Hungarian. - Targeting gut microbiota in obesity: effects of prebiotics and probiotics.
Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD. Delzenne NM, et al. Nat Rev Endocrinol. 2011 Aug 9;7(11):639-46. doi: 10.1038/nrendo.2011.126. Nat Rev Endocrinol. 2011. PMID: 21826100 Review.
Cited by
- Gut Microbiota: A Contributing Factor to Obesity.
Harakeh SM, Khan I, Kumosani T, Barbour E, Almasaudi SB, Bahijri SM, Alfadul SM, Ajabnoor GM, Azhar EI. Harakeh SM, et al. Front Cell Infect Microbiol. 2016 Aug 30;6:95. doi: 10.3389/fcimb.2016.00095. eCollection 2016. Front Cell Infect Microbiol. 2016. PMID: 27625997 Free PMC article. Review. - The effect of psychoactive bacteria, Bifidobacterium longum Rosell®-175 and Lactobacillus rhamnosus JB-1, on brain proteome profiles in mice.
Jarosz ŁS, Socała K, Michalak K, Wiater A, Ciszewski A, Majewska M, Marek A, Grądzki Z, Wlaź P. Jarosz ŁS, et al. Psychopharmacology (Berl). 2024 May;241(5):925-945. doi: 10.1007/s00213-023-06519-z. Epub 2023 Dec 29. Psychopharmacology (Berl). 2024. PMID: 38156998 Free PMC article. - Human Gut Microbiome and Liver Diseases: From Correlation to Causation.
Li R, Mao Z, Ye X, Zuo T. Li R, et al. Microorganisms. 2021 May 8;9(5):1017. doi: 10.3390/microorganisms9051017. Microorganisms. 2021. PMID: 34066850 Free PMC article. Review. - The role of gut microbiota in the gut-brain axis: current challenges and perspectives.
Chen X, D'Souza R, Hong ST. Chen X, et al. Protein Cell. 2013 Jun;4(6):403-14. doi: 10.1007/s13238-013-3017-x. Epub 2013 May 18. Protein Cell. 2013. PMID: 23686721 Free PMC article. Review. - Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice.
Tao F, Xing X, Wu J, Jiang R. Tao F, et al. PLoS One. 2021 Mar 25;16(3):e0248482. doi: 10.1371/journal.pone.0248482. eCollection 2021. PLoS One. 2021. PMID: 33764993 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical